Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1861 AL 1875

The multimodal action of genistein in Alzheimer's and other age-related diseases

Mas-Bargues C, Borrás C, Viña J.

Free Radic Biol Med. 2022 Apr;183:127-137. doi: 10.1016/j.freeradbiomed.2022.03.021. Epub 2022 Mar 26.

Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future

Gouveia F, Camins A, Ettcheto M, Bicker J, Falcão A, Cruz MT, Fortuna A.

Ageing Res Rev. 2022 May;77:101612. doi: 10.1016/j.arr.2022.101612. Epub 2022 Mar 26.

Alzheimer's disease: history, ethics and medical humanities in the context of assisted suicide

Braun B, Demling J, Loew TH.

Philos Ethics Humanit Med. 2022 Mar 30;17(1):4. doi: 10.1186/s13010-021-00111-z.

Role of Pharmacogenomics in Individualizing Treatment for Alzheimer's Disease

Argueta N, Notari E, Szigeti K.

CNS Drugs. 2022 Apr;36(4):365-376. doi: 10.1007/s40263-022-00915-3. Epub 2022 Mar 30.

Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19

Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM.

Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2201-2214. doi: 10.26355/eurrev_202203_28369.

Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer's disease

Dhiman A, Handa M, Ruwali M, Singh DP, Kesharwani P, Shukla R.

Mitochondrion. 2022 May;64:112-124. doi: 10.1016/j.mito.2022.03.006. Epub 2022 Mar 31.

Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease

Fang X, Zhang J, Zhao J, Wang L.

J Healthc Eng. 2022 Mar 25;2022:9148650. doi: 10.1155/2022/9148650. eCollection 2022.

Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review

Azam MS, Wahiduzzaman M, Reyad-Ul-Ferdous M, Islam MN, Roy M.

Pharm Res. 2022 Apr;39(4):611-629. doi: 10.1007/s11095-022-03237-7. Epub 2022 Apr 4.

Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease

Villegas C, Perez R, Petiz LL, Glaser T, Ulrich H, Paz C.

IUBMB Life. 2022 Aug;74(8):763-779. doi: 10.1002/iub.2613. Epub 2022 Apr 5.

γ-Secretase in Alzheimer's disease

Hur JY.

Exp Mol Med. 2022 Apr;54(4):433-446. doi: 10.1038/s12276-022-00754-8. Epub 2022 Apr 8.

Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease

Kumar N, Kumar V, Anand P, Kumar V, Ranjan Dwivedi A, Kumar V.

Bioorg Med Chem. 2022 May 1;61:116742. doi: 10.1016/j.bmc.2022.116742. Epub 2022 Apr 5.

Altered peripheral factors affecting the absorption, distribution, metabolism, and excretion of oral medicines in Alzheimer's disease

Waller ES, Yardeny BJ, Fong WY, Gan XY, Jimenez SV, Pan Y, Abasszade JH, Nicolazzo JA.

Adv Drug Deliv Rev. 2022 Jun;185:114282. doi: 10.1016/j.addr.2022.114282. Epub 2022 Apr 11.

Alzheimer's Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore

Botelho MJ, Milinovic J, Bandarra NM, Vale C.

Mar Drugs. 2022 Apr 2;20(4):253. doi: 10.3390/md20040253.

The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials

Tseng PT, Zeng BY, Chen YW, Yang CP, Su KP, Chen TY, Wu YC, Tu YK, Lin PY, Carvalho AF, Stubbs B, Matsuoka YJ, Li DJ, Liang CS, Hsu CW, Sun CK, Cheng YS, Yeh PY, Shiue YL.

Curr Neuropharmacol. 2022;20(10):1816-1833. doi: 10.2174/1570159X20666220420122322.

ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease

Li Y, Macyczko JR, Liu CC, Bu G.

Neurobiol Aging. 2022 Jul;115:20-28. doi: 10.1016/j.neurobiolaging.2022.03.011. Epub 2022 Mar 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias